Raphaël Liévin

8PUBLICATIONS
167CO-AUTHORS
Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersHaematologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 12, 2024
Biological Findings and Clinical Outcomes in Patients Treated With R-CHOP Plus High-Dose Methotrexate as First-Line Therapy in Large B-Cell Lymphoma With Testis Involvement.

R Liévin, B Burroni, E Balducci

|Sep 30, 2024
Immune reconstitution and evolution of B-cell-stimulating cytokines after R-CHOP therapy for HIV-associated DLBCL.

Raphaël Liévin, Alexis Maillard, Houria Hendel-Chavez

|Apr 24, 2024
Comprehensive Genetic Profiling Reveals Frequent Alterations of Driver Genes on the X Chromosome in Extranodal NK/T-cell Lymphoma.

Yuta Ito, Amira Marouf, Yasunori Kogure

|Apr 14, 2023
Impact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post-CD19-directed CAR T-cell therapy: an EPICOVIDEHA survey.

Jaap A van Doesum, Jon Salmanton-García, Francesco Marchesi

|Sep 20, 2022
Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey.

Livio Pagano, Jon Salmanton-García, Francesco Marchesi

|Jan 30, 2022
Effect of early granulocyte-colony-stimulating factor administration in the prevention of febrile neutropenia and impact on toxicity and efficacy of anti-CD19 CAR-T in patients with relapsed/refractory B-cell lymphoma.

Raphaël Liévin, Roberta Di Blasi, Florence Morin

Pageof 2

Frequent Collaborators

4 joint publications

Caroline Besson

3 joint publications

Iker Falces-Romero

3 joint publications

Irati Ormazabal-Vélez

3 joint publications

Ola Blennow